Table 1.

Demographic characteristics, concomitant comorbidities and vitamin D status in COVID-19 patients and control subjects

	COVID-19 patients (n.73)	Control subjects (n.30)	P value
Age, years	68 [54–73]	65 [62–70]	0.89
Male gender, n. (%)	43 (58.9%)	18 (60%)	>0.99
BMI, kg/m2	27.1 [25–31]	26.6 [24–28.1]	0.1
Overweight, n. (%)	55 (75.3%)	21 (70%)	0.4
Hypertension, n. (%)	42 (57.5%)	20 (66.7%)	0.5
Cardiovascular disease, n. (%)	10 (13.7%)	5 (16.7%)	0.76
Diabetes mellitus, n. (%)	20 (27.4%)	5 (16.7%)	0.31
History of neoplasia, n. (%)	8 (11%)	5 (16.7%)	0.52
25(OH) vitamin D levels, ng/mL	13.8 [8.8–20.1]	23.6 [16.3–28.2]	<0.001
Vitamin D deficiency, n. (%)	55 (75%)	13 (43%)	0.002

n. number, BMI body mass index

P values reported in bold are those statistically significant